# Cardinal Health Inc: Form 10-K for the period ended Jun 30, 2025

- Company: [Cardinal Health Inc](/companies/cah.md) (CIK 721371)
- Form: 10-K
- Filed: 2025-08-12
- Accepted by EDGAR: Aug 12, 2025, 08:58 ET
- Period: 2025-06-30
- Accession: 0000721371-25-000079
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/721371/000072137125000079/cah-20250630.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/721371/000072137125000079/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2025-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 12 months, 2024-07-01 to 2025-06-30 | $222.58bn | us-gaap:Revenues |
| Cost of revenue | 12 months, 2024-07-01 to 2025-06-30 | $214.41bn | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 12 months, 2024-07-01 to 2025-06-30 | $8.17bn | us-gaap:GrossProfit |
| Selling, general and administrative | 12 months, 2024-07-01 to 2025-06-30 | $5.38bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months, 2024-07-01 to 2025-06-30 | $2.27bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months, 2024-07-01 to 2025-06-30 | $215.0m | us-gaap:InterestExpense |
| Income tax | 12 months, 2024-07-01 to 2025-06-30 | $532.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months, 2024-07-01 to 2025-06-30 | $1.56bn | us-gaap:NetIncomeLoss |
| Diluted EPS | 12 months, 2024-07-01 to 2025-06-30 | $6.45 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months, 2024-07-01 to 2025-06-30 | $6.48 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months, 2024-07-01 to 2025-06-30 | 242,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months, 2024-07-01 to 2025-06-30 | $2.40bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months, 2024-07-01 to 2025-06-30 | $547.0m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months, 2024-07-01 to 2025-06-30 | $494.0m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months, 2024-07-01 to 2025-06-30 | $765.0m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | at 2025-06-30 | $3.87bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2025-06-30 | $36.37bn | us-gaap:AssetsCurrent |
| Total assets | at 2025-06-30 | $53.12bn | us-gaap:Assets |
| Current liabilities | at 2025-06-30 | $38.90bn | us-gaap:LiabilitiesCurrent |
| Shareholders' equity | at 2025-06-30 | −$2.78bn | us-gaap:StockholdersEquity |

## Sections

No standard item headings were found in this filing’s main document, so no sections were extracted. Read the original on sec.gov. https://www.sec.gov/Archives/edgar/data/721371/000072137125000079/cah-20250630.htm

Filed Aug 12, 2025.
Source: SEC EDGAR, the filing index for accession 0000721371-25-000079. Last ingested by Listed: Nov 5, 2026, 12:30 ET. No prices; not investment advice.